Find syndicated market insights and custom brand analyses through our services offered in the nephrology market. Spherix’s independent research is conducted by our intelligence teams in collaboration with our proprietary network of nephrologists, patients, and leading KOLs.
According to new research published by Spherix Global Insights, the CKD non-dialysis market is poised for seismic shifts as SGLT2...
According to Spherix Global Insights, specialists in dermatology, gastroenterology, nephrology, neurology, and rheumatology have little interest in engaging with industry,...
The Launch Dynamix™ service includes current tracking of Cosentyx (Novartis) and Taltz (Eli Lilly) in non-radiographic axial spondyloarthritis, Kesimpta (Novartis)...
According to Spherix Global Insights, rheumatologists and nephrologists are excited about new treatment options in addition to a multitude of...
